Business Wire

Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation


Veristat, a scientific-minded global clinical research organization (CRO) and regulatory consultancy, shared today the addition of three seasoned leaders to Veristat’s Executive team. The appointments reflect Veristat’s rapid rate of global growth, supporting sponsors in overcoming the challenges of operating in complex and highly regulated clinical environments.

Elizabeth R. Madichie, Ph.D. joins Veristat as Executive Vice President of Global Regulatory Affairs, responsible for all aspects of the development and implementation of Veristat’s global regulatory services. Elizabeth has over 25 years of experience leading global functions in pharmaceutical, biotech, and CRO organizations, setting strategic priorities, and establishing best practices across regulatory affairs, pharmacovigilance, medical information, market access, and product development in multiple therapeutic areas. Elizabeth possesses expert knowledge of the regulatory and commercial environments and legislative framework for biopharmaceuticals worldwide, enabling the development and commercialization of novel and established products and services across 160+ countries. She currently serves as Past-President and Board Director of The Organization of Professionals in Regulatory Affairs (TOPRA).

Natalia Grassis has been hired as Executive Vice President of Global Clinical Operations and Delivery to oversee Veristat’s end-to-end clinical trial operations. An accomplished business executive with more than two decades of experience in leadership roles at global clinical research organizations and biotech companies, Natalia brings extensive knowledge across all phases of clinical development spanning a number of therapeutic categories, including infectious disease (COVID), gene therapy, rare disease, oncology, and CNS. Her deep experience conducting innovative business process improvement initiatives and driving cutting-edge research with patient-centered virtual clinical trials has resulted in accelerated drug development timelines for clients.

Nan Shao, Ph.D., has been named Executive Vice President of Global Operations to manage and oversee the clinical trial data, analytics, and reporting organization across all regions. A successful business leader, clinical research professional, and statistician with 20 years of pharmaceutical industry experience and ten years leading global biometrics operations and strategic divisions, Nan brings significant expertise in analytics strategy, biostatistics, statistical programming, data management, pharmacokinetics, and data standards. She is highly skilled in the clinical development life cycle across a range of therapeutic areas, collaborating with clients to achieve their operational and business goals.

“Our new leaders bring an abundance of talent and a wealth of experience to Veristat. I am proud to add them to our executive team as we execute our mission of consistently delivering the highest quality clinical development and regulatory services to our global client community,” said Patrick Flanagan, Chief Executive Officer of Veristat. “Elizabeth, Natalia, and Nan each bring years of tactical experience and a well-honed ability to develop and oversee global teams which deliver excellent results for clients. I look forward to seeing our clients advance their clinical and regulatory milestones and benefit from their thoughtful observations and insights.”

More information on Veristat’s executive leadership team can be found at

About Veristat

Veristat, a scientific-minded global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval and commercialization. With more than 29 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.

Veristat's focus on novel drug development has led to success when handling the unknowns that arise across complicated therapeutic areas, such as rare/ultra-rare disease, advanced therapies, oncology, and infectious disease trials. Every day, we apply this knowledge base to solve any program’s clinical, regulatory, statistical, data, or operational challenges, from the simplest to the most complex. Veristat has assembled an extraordinary team of experts worldwide who have mastered therapeutic development intricacies, enabling sponsors to succeed in extending and saving patients’ lives.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Lauren L. Brennan, Vice President of Marketing, Veristat

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Banking Powerhouse SBI Commits to Empowering XDC, Expanding XDC Network's Footprint in Japan31.5.2023 14:19:00 EEST | Press release

XDC Network (represented by TradeFinex Tech Ltd) is pleased to announce its partnership with SBI VC Trade Co. Ltd., a prominent Japan's cryptocurrency exchange within the SBI Group. This strategic collaboration marks a significant milestone for XDC Network as it expands its ecosystem in the Japanese market. XDC Network offers a robust blockchain Network designed specifically for enterprises use cases like trade finance, payments and real world asset tokenization. With a focus on enhancing efficiency in the estimated annual 2,000 trillion yen trade finance market, XDC Network provides high speed transactions and significantly lower gas fees being energy efficient, making it an ideal choice for efficient operations. “We are thrilled to partner with SBI VC Trade and bring the XDC ecosystem to the Japanese market,” said Atul Khekade, co-founder at XDC Network. “Japan is a crucial hub for international trade, and our blockchain platform aims to streamline this sector by improving transparen

Kenvue to Participate in the Deutsche Bank dbAccess Global Consumer Conference on June 8, 202331.5.2023 14:00:00 EEST | Press release

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced the company’s participation in Deutsche Bank’s dbAccess Global Consumer Conference 2023 in Paris. Chief Executive Officer and Director, Thibaut Mongon, and Chief Financial Officer, Paul Ruh, will participate in a fireside chat on Thursday, June 8, 2023, at 12:30 p.m. Central European Summer Time (6:30 a.m. ET). A live webcast of the session will be available at and a replay will be available on the website following the event. About Kenvue Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena®, Tylenol® and Zyrtec® — are recommended by health care professionals and can be trusted by consumers who use our products to improve their daily li

The LYCRA Company’s Sustainability Director Joins Panel Discussion at the United Nations Conscious Fashion and Lifestyle Network Annual Meeting31.5.2023 12:00:00 EEST | Press release

The LYCRA Company, a global leader in developing innovative and sustainable fiber and technology solutions for the apparel and personal care industries, announced today that it is a supporting partner of the United Nations Conscious Fashion and Lifestyle Network Annual Meeting on June 1. The company’s sustainability director, Jean Hegedus, will be a panelist at the meeting taking place at the United Nations Headquarters in New York City that will bring together media, industry stakeholders, and United Nations representatives to highlight actions, solutions, and progress from the fashion and lifestyle sectors to advance knowledge and strengthen engagement of the Sustainable Development Goals. This press release features multimedia. View the full release here: The LYCRA Company’s sustainability director, Jean Hegedus, joins a panel discussion at the United Nations Conscious Fashion and Lifestyle Network Annual Meeting, which takes

Brussels Signal: New Media Outlet Promises to Shake Up EU Coverage31.5.2023 11:03:00 EEST | Press release

Digital publisher Remedia Europe is preparing a groundbreaking news outlet, Brussels Signal , that promises to provide fresh and candid coverage of EU affairs and the issues that matter most to the citizens of Europe. Brussels Signal will deliver rigorous reporting and analysis of the European Union. The news outlet aims to shake up the status quo by providing insightful and informed journalism that challenges prevailing ideas and policies, demands genuine accountability from decision-makers, and counters the marginalisation of dissenting voices on the issues facing Europe today. An early version of Brussels Signal opens May 31 with an invitation to join a live event with the new editors. Other features of the news outlet – including video content and newsletters – will roll out in the coming weeks, with events coming this autumn at the Brussels Signal’s purpose-built studio in the heart of the European Quarter of Brussels. The new media brand emerges at a time when the EU faces intern

Norwegian ISP Altibox chooses Alinto's secure email platform to provide messaging services to its clients31.5.2023 11:00:00 EEST | Press release

Norwegian ISP Altibox has decided to outsource its email platform to Alinto, with the aim of modernising its messaging services for 180 000 clients in the Nordics. The services provided are based on the SOGomail server and the Cleanmail security service, hosted by Alinto. This move happens a few months after the takeover of the SOGo open-source project by Alinto. It confirms the editors’ ability to address projects on an international scale and cover the whole email chain with GDPR-compliant solutions. Modernisation of an email platform used by 180 000 clients Until 2022, Altibox had a messaging platform built and operated in-house. As that platform started to require extensive maintenance operations, Altibox had to move to a new solution. "We had two options : discontinue the service and delete all the emails – which was not acceptable from a client standpoint, or outsource our email services as we did not have any internal resources to create a new solution”, Marius Ekeland explains.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom